Table 2

Summary information per RCT assessed for MVHT using refined set of domains and judgmental criteria

Paper

Attributes of RCT


First author, year

Medical condition studied

Homeopathic intervention

Comparison group

'Main' outcome measure

Length of follow-up


Lewith, 2002 [26]

Allergic asthma

House dust mite

Placebo

Asthma VAS

16 wk


Kainz, 1996 [27]

Warts

Individualised

(from 10 options)

Placebo

Responders: patients with at least 50% reduction in area of skin affected by warts

8 wk


McCutcheon, 1996 [28]

Anxiety

Combination

(9 medicines)

Placebo

State Anxiety score

15 d


Bell, 2004 [29]

Fibromyalgia

Individualised

Placebo

Tender point pain on palpation

3 mo


Robertson, 2007 [30]

Post-operative pain

Arnica montana

Placebo

Change in tonsillectomy pain score (VAS)

14 d


Adler, 2009 [31]

Depression

Individualised

Fluoxetine

Change in MADRS score from baseline

8 wk


'Main' outcome measure was identified per RCT using the WHO International Classification of Functioning, Disability and Health, 2002 [32]

MADRS Montgomery & ├ůsberg Depression Rating Scale

VAS Visual Analogue Scale

Mathie et al. BMC Medical Research Methodology 2012 12:49   doi:10.1186/1471-2288-12-49

Open Data